As we enter January, the month dedicated to raising awareness about cervical cancer, it is crucial to emphasize the significance of early detection and prevention of this prevalent but preventable disease. (1,2,3,4,5) This Cervical Cancer Awareness Month, we are delighted to announce the collaborative efforts of BioReference Health and Teal Health in supporting a groundbreaking […]
Tag Archives: HPV
Press Release
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
09
Feb
Feb
CINtec® PLUS Cytology offered as a reflex test when cytology is NILM and HPV positive ELMWOOD PARK, NJ, February 9, 2023 – BioReference® Health LLC, one of the largest full-service specialty laboratories in the United States, announced today it will be one of the first commercial laboratories to use offer the CINtec® PLUS Cytology test from […]
09
Feb
Feb
Cervical cancer is one of the most preventable forms of cancer. However, each year in the United States, an estimated 13,000 new cases of cervical cancer are diagnosed and 4,000 women die of this cancer, according to the Centers for Disease Control and Prevention. Screening tests and the HPV vaccine are the keys to prevention. When cervical cancer […]
